首页> 外文期刊>Surgical neurology >Intracranial arteriovenous malformations treated with linear accelerator-based conformal radiosurgery: clinical outcome and prediction of obliteration.
【24h】

Intracranial arteriovenous malformations treated with linear accelerator-based conformal radiosurgery: clinical outcome and prediction of obliteration.

机译:基于线性加速器的保形放射外科手术治疗颅内动静脉畸形:临床疗效和闭塞预测。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Little is written about the clinical outcome and predictor factors of obliteration and treatment success in patients with intracranial AVMs treated with LINAC-based conformal radiosurgery in Mexican institutions. METHODS: We analyzed 40 patients with intracranial AVMs with a mean follow-up of 29 (range, 23-34) months. Seven AVMs (17.5%) had a volume <1 cm(3); 10 (25%), 1 to 4 cm(3); 13 (32.5%), 4.1 to 10 cm(3); and 10 (25%), >10 cm(3). The mean prescription dose was 15.4 Gy. Twenty-six patients (68%) presented hemorrhage before treatment; 4 (10%), chronic headache; 14 (35%), seizures; and 3(8%), neurologic deficit. RESULTS: Seven patients (17.5%) underwent objective clinical improvement. Thirty patients (75%) remained without clinical changes. Three patients (7.5%) developed edema and 1 (2.5%) had a rebleeding after treatment. Twenty-five patients (63%) presented complete obliteration of the AVM. A successful treatment (obliteration without a new deficit) was obtained in 23 (58%) of the cases. The percentage of obliteration was in <1 cm(3) (86%), 1 to 4 cm(3) (80%), 4.1 to 10 cm(3) (54%), and >10 cm(3) (40%), without a significant difference between groups (P = .1). Patients with RBAS of 1.9, 48%; the successful treatment in the former resulted in 79% and, in the latter, 38% (P = .08 and P = .02, respectively). CONCLUSIONS: The clinical outcome was similar to other series. The RBAS seems to be a good predictor of obliteration and successful treatment in patients with AVMs treated with LINAC-based conformal radiosurgery.
机译:背景:关于在墨西哥机构中使用基于LINAC的适形放射外科手术治疗的颅内AVM患者的临床结局以及闭塞和治疗成功的预测因素的文献很少。方法:我们分析了40例颅内AVM患者,平均随访时间为29(23-34)个月。七个AVM(17.5%)的体积小于1厘米(3); 10(25%),1-4 cm(3); 13(32.5%),4.1至10 cm(3);和10(25%),> 10厘米(3)。平均处方剂量为15.4 Gy。治疗前有26例(68%)出血; 4(10%),慢性头痛; 14(35%),癫痫发作; 3%(8%)神经系统缺陷。结果:7例(17.5%)进行了客观的临床改善。 30例患者(75%)没有临床改变。 3名患者(7.5%)出现水肿,而1名(2.5%)在治疗后出现了再出血。 25名患者(63%)完全闭塞了AVM。 23例(58%)获得了成功的治疗(闭塞,没有新的缺陷)。遮盖百分比分别为<1 cm(3)(86%),1至4 cm(3)(80%),4.1至10 cm(3)(54%)和> 10 cm(3)(40 %),两组之间无显着差异(P = .1)。 RBAS <或= 1.9的患者闭塞率达79%,> 1.9的患者闭塞率达48%;前者的成功治疗导致79%,后者的治疗率为38%(分别为P = .08和P = .02)。结论:临床结果与其他系列相似。对于基于LINAC的适形放射外科治疗的AVM患者,RBAS似乎是闭塞和成功治疗的良好预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号